Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Symrise Acquires Global Fragrance Business Of Belmay Group - Quick Facts

3/4/2013 9:11 AM ET

Symrise AG (SYIEF.PK,SYIEY.PK) announced it has acquired the global fragrance business of the Belmay Group, an international developer and manufacturer of fragrances and perfume oils. The companies have agreed to keep the purchase price confidential.

The Belmay Group, headquartered in Yonkers, New York, is a developer and manufacturer of fragrance creations, particularly in the segments fine fragrances, cosmetics and air care. Belmay generated fragrance sales of around US$60 million in fiscal 2012. At the beginning of 2012, Symrise took over Belmay's Brazilian fragrance business.

Click here to receive FREE breaking news email alerts for Symrise Ag and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks continue to show a lack of direction in mid-day trading on Thursday, extending the lackluster performance seen earlier in the session. The major averages have spent the day bouncing back and forth across the unchanged line. After speaking with President Barack Obama by phone about stalled immigration reform legislation on Wednesday, House Majority Leader Eric Cantor, R-Virg., claimed the president still does not understand how to work with the Republican-controlled House. Growth in Philadelphia-area manufacturing activity has accelerated by much more than anticipated in the month of April, according to the results of the Federal Reserve Bank of Philadelphia's Business Outlook Survey released on Thursday. The Philly Fed said its diffusion index of current activity climbed to 16.6 in April from 9.0 in March, with a positive reading indicating growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.